Genocea Biosciences Employee Directory
Biotechnology ResearchMassachusetts, United States51-200 Employees
Genocea Biosciences is a biotechnology research company based in Cambridge, Massachusetts, focusing on identifying tumor targets to develop immunotherapies for cancer. Its ATLAS platform analyzes a patient’s T cell responses to potential tumor antigens, aiming to distinguish those that activate anti-tumor activity from inhibitory antigens that may support tumor growth. The company is advancing a Phase 1/2a program for GEN-011, an adoptive T cell therapy, and is monitoring a Phase 1/2a neoantigen vaccine trial, GEN-009, with additional research exploring how ATLAS could optimize antigen selection across various therapeutic areas. Genocea operates within the biopharmaceutical sector, working on next-generation neoantigen immunotherapies and collaborating on efforts to understand antigen immunogenicity and the role of inhibitory antigens in cancer therapy. Recent activity includes leadership changes and partnerships, such as a collaboration with Janssen Biotech to explore neoantigen immunogenicity and Inhibigens™ in cancer vaccines.